May 12, 2020 / 11:27 AM / 13 days ago

BRIEF-Galera Therapeutics Reports Q1 Loss Per Share Of $0.74

May 12 (Reuters) - Galera Therapeutics Inc:

* GALERA THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

* Q1 LOSS PER SHARE $0.74

* GALERA THERAPEUTICS - ROMAN PHASE 3 TRIAL TOPLINE DATA READOUT GUIDANCE UPDATED TO 2H21 DUE TO IMPACT OF COVID-19

* GALERA THERAPEUTICS - AMENDMENT TO ROYALTY AGREEMENT FOR ADDITIONAL $37.5MLN EXTENDS CASH RUNWAY INTO 2H22 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below